This article analyses regulatory data protection in India under TRIPS and domestic law. It discusses the balance between originator protection and access to generic medicines, highlighting the implications for public health and the pharmaceutical industry.
Read more about Pharmaceutical Regulatory Data Protection in IndiaTag: generic medicines
India protests against The European Union Trademark Reforms
India has protested the European Union’s recent trademark reforms, highlighting concerns over potential seizures of legal pharmaceutical shipments in transit. The issue has been raised at the WTO, with India stressing possible TRIPS Agreement violations and adverse impacts on its generic medicine exports.
Read more about India protests against The European Union Trademark ReformsEU Trademark law threatens Indian Generic Export Market
The EU’s revised trademark law empowers customs to seize in-transit goods, raising serious concerns for Indian generic pharmaceutical exports. This development challenges established principles of territorial trademark enforcement and threatens global access to affordable medicines.
Read more about EU Trademark law threatens Indian Generic Export Market